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Klebsiella pneumoniae isolates that produce carbap-
enemases (KPCs) are rapidly disseminating worldwide. 
To determine their genetic background, we investigated 
16 blaKPC-2-harboring K. pneumoniae isolates from 5 coun-
tries. The isolates were multidrug resistant, possessed the 
blaKPC-2 gene, and differed by additional β-lactamase con-
tent. They harbored a naturally chromosome-encoded bla 
gene (blaSHV-1 [12.5%], blaSHV-11 [68.7%], or blaOKP-A/B [18.8%]) 
and several acquired and plasmid-encoded genes (blaTEM-1 
[81.3%],  blaCTX-M-2 [31.3%], blaCTX-M-12 [12.5%], blaCTX-M-15 
[18.7%], and blaOXA-9 [37.5%]). The blaKPC-2 gene was always 
associated with 1 of the Tn4401 isoforms (a, b, or c). Tn4401 
was inserted on different-sized plasmids that belonged to 
different incompatibility groups. Several blaKPC-containing 
K. pneumoniae clones were found: 9 different pulsotypes 
with 1 major (sequence type 258) and 7 minor distinct al-
lelic proﬁ  les. Different clones harboring different plasmids 
but having identical genetic structure, Tn4401, could be at 
the origin of the worldwide spread of this emerging resis-
tance gene.
R
esistance of Klebsiella pneumoniae to carbapenems is 
mainly associated with acquired carbapenem-hydro-
lyzing β-lactamases (1). These β-lactamases can be metallo 
β-lactamases (IMP, VIM), expanded-spectrum oxacillinas-
es (OXA-48), or Ambler class A enzymes (NMCA, IMI, 
SME, GES, and KPC) (1–4). The most common class A 
carbapenemases in K. pneumoniae are the K. pneumoniae 
carbapenemases (KPCs) (4). KPCs in carbapenem-resis-
tant K. pneumoniae strains were ﬁ  rst reported in 2001 in 
North Carolina (5), and until 2005, the geographic distribu-
tion of these enzymes in Enterobacteriaceae, including K. 
pneumoniae, was limited to the eastern part of the United 
States (5,6). Now, KPC-producing K. pneumoniae isolates 
are frequently identiﬁ  ed among nosocomial pathogens (7). 
Recently, dissemination of a single major clone of KPC-
producing K. pneumoniae (sequence type [ST] 258) in the 
eastern United States has been suggested (8). KPCs have 
been observed more rarely among other gram-negative 
rods such as Pseudomonas spp. (9,10).
Outside the United States, KPC-producing K. pneu-
moniae are also being reported more often. The ﬁ  rst case 
of KPC-producing K. pneumoniae infection was reported 
in 2005 in France and had a US origin (11). The ﬁ  rst out-
break of KPC-producing K. pneumoniae outside the United 
States was in Israel (12). In South America, dissemination 
of KPC-producing K. pneumoniae was initially reported 
in 2006 in Colombia (13) and then in Brazil and Argen-
tina (14,15). KPC enzymes have also been identiﬁ  ed in P. 
aeruginosa isolates from Colombia (16). In the People’s 
Republic of China, KPC enzymes in several enterobacte-
rial species are being increasingly reported (17). Finally, 
in Europe a few cases of KPC-producing K. pneumoniae 
infection have been described, but in Greece, outbreaks 
have occurred (18). In Europe, different variants of KPCs 
(KPC-2 and KPC-3) have been described; some patients 
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carrying KPC-positive isolates had been transferred from 
the United States, Israel, or Greece (19–21).
Reports of this β-lactamase being found in novel lo-
cations are increasing worldwide, probably signaling ac-
tive spread. The genetic element carrying the blaKPC-2 gene, 
Tn4401, was recently elucidated (22). Three isoforms of 
this Tn3-like transposon (a, b, and c) are known. Several 
other genetic environments of blaKPC gene have been de-
scribed; other insertion sequences have been found up-
stream of the blaKPC gene (23,24). Nevertheless, the down-
stream sequences of the blaKPC gene matched perfectly with 
Tn4401, which suggests that these insertion sequences have 
been inserted into Tn4401.
 Insertion sequences may play major roles in the evo-
lution of Tn4401, but little information is available about 
the bacterial strains and the plasmids that may explain this 
rapid spread. Our goal, therefore, was to characterize the 
genetic background of several blaKPC-2- harboring K. pneu-
moniae isolates from various geographic origins.
Materials and Methods
Bacterial Strains
K. pneumoniae isolates used in this study and their ori-
gin are listed in Table 1 (11,13,16,21,25). Electrocompe-
tent Escherichia coli DH10B (Invitrogen, Eragny, France) 
was used as a recipient in electroporation experiments. E. 
coli J53AzR, which is resistant to sodium azide, was used 
for conjugation experiments. E. coli 50192 was used as a 
reference strain for plasmid extraction (22).
Antibiograms and MIC Determinations
 Antibiograms were created by using the disk-diffu-
sion method on Mueller-Hinton agar (Bio-Rad Labora-
tories, Marnes-La-Coquette, France), and susceptibility 
break points were determined as previously described and 
interpreted as recommended by the Clinical and Labora-
tory Standards Institute (22,26). All plates were incubated 
at 37°C for 18 h. MICs of β-lactams were determined by 
using the Etest technique (bioMérieux, Marcy l’Etoile, 
France).
Electroporation and Plasmid Extraction
Direct transfer of resistance into azide-resistant E. coli 
J53 was attempted as reported (22). Plasmids were intro-
duced by electroporation into E. coli DH10B (22) by using 
a Gene Pulser II (Bio-Rad Laboratories).
Plasmid DNA was extracted by using a QIAGEN 
Plasmid Maxi Kit (QIAGEN, Courtaboeuf, France) and 
analyzed by agarose gel electrophoresis (Invitrogen, Par-
is, France). Natural plasmids were extracted by using the 
Kieser extraction method (27) and subsequently analyzed 
by electrophoresis on a 0.7% agarose gel.
Hybridization
 DNA–DNA hybridization was performed as de-
scribed by Sambrook et al. (28) with Southern transfer of 
an agarose gel containing Kieser method–extracted total 
DNA. The probe consisted of a 796-bp PCR-generated 
fragment from recombinant plasmid pRYC-1 (22) and 
was internal to the blaKPC-2 gene. Labeling of the probe 
and detection of signal were conducted by using an ECL 
nonradioactive labeling and detection kit according to the 
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Table 1. Geographic origin and structure of Tn4401 and other E-lactamases of Klebsiella pneumoniae isolates* 
Isolate
no. Isolate type  Origin 
PCR result 
KPC-2 
Tn4401 Other E-lactamases 
TnpA ISKPN7 ISKPN6 Deletion,  bp SHV TEM CTX-M  OXA 
1 YC USA + + + + –100  SHV-11  TEM-1  – OXA-9 
2 GR Greece  + + + + –100 SHV-11  TEM-1  – OXA-9 
3 K271 Sweden + + + + –100  SHV-11  TEM-1  – OXA-9 
4 KN2303 Colombia + + + + None  SHV-11  – – –
5 KN633 Colombia + + + + None  OKP-A  TEM-1  CTX-M-12 –
6 INC H1521-6  Colombia + + + + None  SHV-1  TEM-1  CTX-M-15 –
7 INC H1516-6  Colombia + + + + None  SHV-1  TEM-1  CTX-M-15 –
8 HPTU 27635  Colombia + + + + None  OKP-B  – – –
9 HPTU
2020532 
Colombia + + + + None OKP-A  TEM-1  CTX-M-12 –
10 A28006 Brazil + + + + None SHV-11  TEM-1  CTX-M-2  –
11 A28008 Brazil + + + + None SHV-11  TEM-1  CTX-M-2  –
12 A28009 Brazil + + + + None SHV-11 TEM-1 CTX-M-2  –
13 A28011 Brazil + + + + None  SHV-11  TEM-1  CTX-M-2  OXA-9 
14 A33504 Brazil + + + + None  SHV-11  TEM-1  CTX-M-2  OXA-9 
15 475 Israel + + + + –200 SHV-11  – CTX-M-15 –
16 588 Israel + + + + –200 SHV-11  TEM-1  – OXA-9 
*KPC, K. pneumoniae carbapenemase.  Diversity of K. pneumoniae That Produces KPC 
manufacturer’s instructions (Amersham Biosciences, Or-
say, France).
PCR Ampliﬁ  cation and Sequencing
 The blaCTX-M-, blaSHV-, blaTEM-, and blaOXA-1/9-like genes 
were searched for and characterized as described (21). PCR 
experiments were performed on an ABI 2700 thermocycler 
(Applied Biosystems, Les Ulis, France) by using labora-
tory-designed primers (Table 2). PCR products were then 
analyzed on agarose gel and sequenced.
Both strands of the PCR products were sequenced by 
using laboratory-designed primers with an automated se-
quencer (ABI PRISM 3100; Applied Biosystems). The nu-
cleotide and the deduced protein sequences were analyzed 
by using software from the National Center for Biotechnol-
ogy Information (www.ncbi.nlm.nih.gov).
Isoelectrofocusing
 Crude β-lactamase extracts, obtained as described 
(21) from 10-mL cultures of clinical isolates and their E. 
coli transconjugants or electroporants were subjected to 
analytical isoelectrofocusing on an ampholine-containing 
polyacrylamide gel, pH 3.5–9.5 (Ampholine PAG plate; 
GE Healthcare, Orsay, France) for 90 min at 1,500 volts, 
50 milliamps, and 30 watts. The focused β-lactamases were 
detected by overlaying the gel with 1 mmol nitroceﬁ  n (Ox-
oid, Dardilly, France). Isoelectric points were determined 
and compared with those of known β-lactamases (22).
Pulsed-ﬁ  eld Gel Electrophoresis
Pulsed-ﬁ   eld gel electrophoresis (PFGE) was per-
formed by using XbaI (GE Healthcare) as described (29). 
XbaI-macrorestriction patterns were interpreted according 
to the recommendations of Tenover et al. (30).
Multilocus Sequence Typing
Multilocus sequence typing (MLST) with 7 house-
keeping genes (rpoB,  gapA,  mdh,  pgi,  phoE,  infB,  and 
tonB) was performed according to Diancourt et al. (31). Al-
lele sequences and STs were veriﬁ  ed at http://pubmlst.org/
kpneumoniae. A different allele number was given to each 
distinct sequence within a locus, and a distinct ST number 
was attributed to each distinct combination of alleles.
Replicon and Transposon Typing
 PCR-based replicon typing of the main plasmid in-
compatibility groups reported for Enterobacteriaceae was 
performed as described (32). Genetic structures surround-
ing the blaKPC-2 gene were determined according to the 
Tn4401 PCR-mapping scheme as described (22).
Results
Pulsotypes
Molecular typing by PFGE identiﬁ   ed 9 major pul-
sotypes among the isolates (Table 3). The ﬁ  rst pulsotype 
(pulsotype A) corresponded to the strains from the United 
States and Greece. We found 4 different pulsotypes (B–E) 
among strains from Colombia, which suggested polyclonal 
diffusion inside this country. We also identiﬁ  ed 2 differ-
ent clones among strains from Brazil (pulsotypes F and G) 
and from Israel (pulsotypes H and I). These results indicate 
much heterogeneity among KPC-producing isolates from 
various geographic regions.
MLST of the 16 isolates resulted in 8 distinct allelic 
proﬁ   les: ST 258 (allelic proﬁ   le 3–3-1–1-1–1-79) corre-
sponding to isolates K. pneumoniae YC (United States), 
K. pneumoniae GR (Greece), and K. pneumoniae K271 
(Greece); ST 14 (allelic proﬁ  le  1–6-1–1-1–1-1)  corre-
sponding to isolates K. pneumoniae INC H1521–6 and 
K. pneumoniae INC H1516–6 (Colombia); ST 11 (allelic 
proﬁ  le 3–3-1–1-1–1-4) corresponding to isolates from Bra-
zil; ST 277 (allelic proﬁ  le 3–1-1–1-1–1-43) correspond-
ing to isolate K. pneumoniae 475 (Israel); novel ST 337 
(allelic proﬁ  le 2–1-11–1-1–1-13) corresponding to isolate 
K. pneumoniae KN2303 (Colombia); ST 338 (allelic pro-
ﬁ  le 17–19–22–39–34–21–52) corresponding to isolates K. 
pneumoniae KN633 and K. pneumoniae HPTU 2020532 
(Colombia); ST 339 (allelic proﬁ  le 18–15–25–24–11–13–
51) corresponding to isolate K. pneumoniae HPTU 27635 
(Colombia); and ST 340 (allelic proﬁ  le 3–3-1–1-1–1-18) 
corresponding to isolate K. pneumoniae 588 (Israel). The 
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Table 2. Primers used for PCR of Klebsiella pneumoniae  
isolates producing ȕ-lactamase blaKPC-2 gene* 
Primer name  Primer no.†   Sequence, 5ƍ o 3ƍ 
KpcA 1  CTGTCTTGTCTCTCATGGCC 
KpcB 2  CCTCGCTGTGCTTGTCATCC 
4281 3  GGCACGGCAAATGACTA 
4714 4  GAAGATGCCAAGGTCAATGC 
EcoRIout 5  CACCCGACCTGGACGAACTA 
3ƍYCEnd 6  GCATCAAACGGAAGCAAAAG 
3781L 7  CACAGCGGCAGCAAGAAAGC 
3098U 8  TGACCCTGAGCGGCGAAAGC 
905L 9  GCGACCGGTCAGTTCCTTCT 
816U 10  CACCTACACCACGACGAACC 
141R-6 11  TCACCGGCCCTCACCTTTGG 
5ƍendYC 12  CTTAGCAAATGTGGTGAACG 
Pre-SHV-5 U  –  GGTCAGCGCGAGAAGCATCC 
Pre-SHV-5 L  –  AAATAGCGTTCATCGTCAAT 
Pre-TEM 1  –  GTATCCGCTCATGAGACAATA 
Pre-TEM 2  –  TCTAAAGTATATATGAGTAAA 
CTTGGTCTG 
OXA-9 A  –  TTCGTTTCCGCCACTCTCCC 
OXA-9 B  –  ACGAGAATATCCTCTCGTGC 
CTX-M A  –  CGCTTTGCGATGTGCAG 
CTX-M B  –  ACC GCG ATA TCG TTG GT 
*Primers from (21). 
†Numbers correspond to those in Figure 1, panel A. –, primer not shown  
in Figure 1, panel A.  RESEARCH
analysis of STs by eBURST (http://pubmlst.org) showed 
that ST 11 and ST 340 are single-locus variants of ST 258 
and that ST 277 is a double-locus variant of ST 258. These 
results matched perfectly with PFGE results. One isolate 
from Brazil (K. pneumoniae A33504) showed a different 
pattern by PFGE but the same ST (ST 11) as other isolates 
from the same origin, which suggests a strong genetic re-
latedness.
Antimicrobial Drug Susceptibility
All isolates were resistant to penicillins and cepha-
losporins but showed varying levels of susceptibility to 
carbapenems (Table 4). Resistance to other drug classes 
varied among the isolates. For aminoglycosides, 2 clones 
(A and I) were susceptible to gentamicin only, 1 clone (H) 
was susceptible to amikacin only, and 3 clones (C, D, and 
G) were resistant to all tested aminoglycosides. Six clones 
(A, C, D, F, G, and I) showed resistance to ﬂ  uoroquinolo-
nes. Percentages of nonsusceptible isolates to the non–β-
lactam drugs were as follows: gentamicin, 75%; amikacin, 
81.3%; ciproﬂ   oxacin, 81.5%; trimethoprim/sulfamethox-
azole, 81.5%; and tetracycline, 87.5%. Two isolates were 
also resistant to colistin (K. pneumoniae GR and K. pneu-
moniae K271); each was from Greece, where this drug is 
often used (33).
β-Lactamase Genes
Positive results of CTX-M–, TEM-, SHV-, and 
OXA-speciﬁ  c PCRs are indicated in Table 1. All isolates 
possessed the blaKPC-2 gene and a naturally chromosome-
encoded bla gene: blaSHV-1 (12.5%), blaSHV-11 (68.7%), or 
blaOKP-A/B (18.8%). The blaOKP genes are 1 of the 3 families 
of the chromosomal β-lactamase genes found in K. pneu-
moniae (34) with blaSHV and blaLEN and share 88% similar-
ity with blaSHV-1. K. pneumoniae isolates also harbored sev-
eral acquired and plasmid-encoded genes: blaTEM-1 (81.3%), 
blaCTX-M-2 (31.3%), blaCTX-M-12 (12.5%), blaCTX-M-15 (18.7%), 
and blaOXA-9 (37.5%).
Characterization Results for Tn4401
Primer couples speciﬁ  c for the different genes found on 
Tn4401 (Table 2; Figure 1, panel A) obtained similar-sized 
fragments for all strains, which suggests that the strains 
have a similar genetic organization. For only 1 primer pair, 
hybridizing in ISKpn7 and blaKPC gene (primers 7 and 8 in 
Figure 1, panel A), located upstream of the blaKPC gene, 
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Table 3. Plasmid analysis, pulsotype, and sequence type of Klebsiella pneumoniae isolates from 5 countries* 
Isolate
no. Isolate name 
Plasmids
PFGE type
MLST
ST Size, kb  Inc gap infB mdh pgi phoE rpo  tonB
1 YC 80 FiiAS A 3 3 1 1 1 1 79 258
2 GR 80 FiiAS A 3 3 1 1 1 1 79 258
3 K271 80 FiiAS A 3 3 1 1 1 1 79 258
4 KN2303 75,  35  N B 2 1 11 1 1 1 13 337
5 KN633 12 ND  C 17 19 22† 39 34† 21 52 338
6 INC H1521-6  75 L/M D 1 6 1 1 1 1 1 14
7 INC H1516-6  75 L/M D 1 6 1 1 1 1 1 14
8 HPTU 27635  35 L/M E 18 15 25† 24 11† 13 51 339
9 HPTU 2020532  12 ND  C 17 19 22† 39 34† 21 52 338
10 A28006 12 L/M F 3 3 1 1 1 1 4 11
11 A28008 12 L/M F 3 3 1 1 1 1 4 11
12 A28009 12 L/M F 3 3 1 1 1 1 4 11
13 A28011 12 L/M F 3 3 1 1 1 1 4 11
14 A33504 50 ND  G 3 3 1 1 1 1 4 11
15 475 80 N H 3 1 1 1 1 1 43 277
16 588 70 N I 3 3 1 1 1 1 18 340
*Countries shown in Table 1. PFGE, pulsed-field gel electrophoresis; MLST, multilocus sequence type; ST, sequence type; ND, could not be determined 
with the Inc primers tested. 
†Alleles are variants of previously described alleles (Figure 2). 
Table 4. MICs of carbapenems for clinical Klebsiella
pneumoniae isolates expressing KPC-2 ȕ-lactamase* 
Isolate type
Carbapenem MIC, mg/L 
Imipenem Meropenem  Ertapenem 
YC    4    2   24 
GR   12    6   12 
K271    4    4   16 
KN2303  >32 >32 >32 
KN633  >32    4  >32 
INC H1521-6    6    3    8 
INC H1516-6    4    4   32 
HPTU 27635    4    2   12 
HPTU 2020532   16   16   24 
A28006   16    32   24 
A28008   24    16   32 
A28009 >32    >32  >32 
A28011 >32    >32  >32 
A33504 >32    >32  >32 
475  16   >32  >32 
588  24    16   32 
*KPC, K. pneumoniae carbapenemase.  Diversity of K. pneumoniae That Produces KPC 
an ≈100-bp (K. pneumoniae YC, K. pneumoniae GR, and 
K. pneumoniae 271) or 200-bp (K. pneumoniae 475 and 
K. pneumoniae 588) shorter fragment was observed, com-
pared with the Tn4401b structure, thus indicating that the 
3 isoforms of Tn4401 were present in this collection of 
isolates (Figure 1, panel B).
To investigate the ﬂ  anking sequences of Tn4401, we 
used PCR primers located in the Tn4401 structure and in 
the ﬂ  anking sequences derived from K. pneumoniae YC 
(22). PCR products of expected size were obtained for K. 
pneumoniae GR and K. pneumoniae K271 isolates only. 
For all other strains, no PCR product could be obtained, 
suggesting that the Tn4401 insertion site might differ from 
that found in K. pneumoniae YC.
Genetic Support for blaKPC in the Isolates
The carbapenem-resistant K. pneumoniae isolates con-
tained several plasmids of different sizes, ranging from 
<5 kb to >170 kb (Figure 2, left panel). At least 1 plas-
mid hybridized with an internal probe for blaKPC-2 gene in 
each isolate, ranging from 13 kb to 80 kb (Figure 2, right 
panel; Table 3). We observed 2 hybridization signals (35 
kb and 75 kb) for K. pneumoniae KN2303, as described 
(22). Plasmid location of the blaKPC genes was conﬁ  rmed 
by electroporation of these plasmids into E. coli DH10B, 
but no transformant could be obtained for K. pneumoniae 
2020532. The E. coli transformants had a β-lactam re-
sistance pattern that corresponded to the expression of a 
blaKPC-like gene. Electroporation of 4 plasmids harboring 
the blaKPC-like gene into E. coli DH10B conferred resistance 
to at least an aminoglycoside molecule; pINC-H1521–6, 
pA33504, and p588 conferred resistance to all aminogly-
cosides except gentamicin, and electroporation of p475 
into E. coli DH10B led to resistance to all aminoglycosides 
tested. No other antimicrobial drug resistance marker was 
cotransferred; the transformants remained susceptible to 
nalidixic acid, levoﬂ  oxacin, ciproﬂ  oxacin, rifampin, tetra-
cycline, trimethoprim/sulfamethoxazole, and colistin.
Mating-out assays showed that the ≈75–80-kb plas-
mids harboring blaKPC-2 from K. pneumoniae YC, GR, 
K271, and KN2303 were self-transferable to E. coli. The 
smaller plasmid from K. pneumoniae KN633 was not trans-
ferred to E. coli.
Origin of Replication
PCR-based replicon typing of the major plasmid in-
compatibility groups showed that the blaKPC-2-positive 
plasmids belonged to at least 3 incompatibility groups (In-
cFIIAS, IncN, and IncL/M) (Table 3). The plasmids of K. 
pneumoniae KN633, HPTU-2020532 from Colombia and 
K. pneumoniae A33504 from Brazil gave negative results 
with the Inc primers tested and could not be classiﬁ  ed into 
a major plasmid incompatibility group.
Discussion
Rapid spread of KPC-producing K. pneumoniae is 
a major clinical and public health concern. These broad-
spectrum  β-lactamases are increasing in new locations 
worldwide, indicating an ongoing process. Recently, a 
novel Tn3-based transposon, Tn4401, was identiﬁ  ed  in 
nonclonally related KPC-producing K. pneumoniae and P. 
aeruginosa isolates (22). This transposon is in most recent-
ly described isolates (20,35,36), although a recently char-
acterized novel variant from China had another insertion 
sequence inserted upstream of blaKPC gene (24). Identiﬁ  ca-
tion of Tn4401 inserted at different loci, on different plas-
mids, and ﬂ  anked by different 5-bp target site duplications 
indicates a frequent and dynamic process of transposition. 
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Figure 1. A) Schematic  representation of Tn4401 isoforms 
on plamids of Klebsiella pneumoniae isolates that produce 
K. pneumoniae carbapenemases (KPCs). Genes and their 
corresponding transcription orientations are indicated by horizontal 
arrows. Gray triangles represent the inverted repeats left (IRL) and 
right (IRR) of Tn4401. Small and empty triangles represent the 
inverted repeats of ISKpn6 and ISKpn7. Target site duplications 
(TSD) are indicated above the sequence. Primers listed in Table 
2 are shown below, with results of PCRs for each isolate. B) PCR 
results with primers 7 and 8 (Table 2). Lane 1, K. pneumoniae YC 
(11); lane 2, K. pneumoniae GR (21); lane 3, K. pneumoniae K271 
(25); lane 4, K. pneumoniae KN2303 (13); lane 5, K. pneumoniae 
KN633 (13); lane 6, K. pneumoniae INC H1521-6; lane 7, K. 
pneumoniae INC H1516-6; lane 8, K. pneumoniae HPTU 27635; 
lane 9, K. pneumoniae HPTU 2020532; lane 10, K. pneumoniae 
A28006 (16); lane 11, K. pneumoniae A28008 (16); lane 12, K. 
pneumoniae A28009 (16); lane 13, K. pneumoniae A28011 (16); 
lane 14, K. pneumoniae A33504 (16); lane 15, K. pneumoniae 475; 
lane 16, K. pneumoniae 588; lane 17, PCR products of expected 
size with no deletion; lane 18, PCR products of expected size with 
100-bp deletion; lane 19, PCR products of expected size with 200-
bp deletion. RESEARCH
It has been suggested that this novel transposon is at the or-
igin of blaKPC-like gene acquisition and dissemination (22). 
Sixteen K. pneumoniae isolates that express the blaKPC gene 
from 5 countries were characterized here.
PFGE and MLST showed that several clones are cur-
rently spreading in different geographic locations. In Co-
lombia, 3 pulsotypes could be identiﬁ  ed. Overall, among 
the 16 isolates, 1 major ST (258) and its derivative ST 11 
seemed to predominate. In a recent study that gathered 
isolates from 10 US states, ST 258 accounted for 70% 
of isolates, according to a database of KPC-producing K. 
pneumoniae PFGE results maintained by the Centers for 
Disease Control and Prevention (8). This ST has also been 
identiﬁ  ed for KPC-producing K. pneumoniae in Sweden 
(in isolates imported from Greece and Israel) and more 
recently in Poland (36,37). These ﬁ  ndings suggest pos-
sible international dissemination of KPC-producing ST 
258. Apparently, the K. pneumoniae clone that contains 
the extended-spectrum β-lactamase (ESBL) determinant 
CTX-M-15 belongs to ST 11 (38).
KPC-producing  K. pneumoniae contained diverse 
β-lactamases. All except 2 isolates harbored at least an-
other  β-lactamase;  blaTEM-1 and a blaCTX-M-type ESBLs 
were expressed by >80% and 62.5% of isolates, respec-
tively. KPC producers have already been associated with 
other  β-lactamase genes, such as the widespread ESBL 
gene blaCTX-M-15 (17). SHV ESBLs have been found among 
isolates, as has been described for strains from the United 
States (39) and Norway (36). These additional β-lactamases 
are likely to complicate phenotype-based identiﬁ  cation of 
KPC producers. Three isolates harbored the chromosome-
encoded  blaOKP-A/B genes and belonged to phylogenetic 
group KpII, which accounts for <10% of K. pneumoniae 
strains (34). Coexpression of OKP enzymes and ESBLs has 
rarely been reported.
Isolates also demonstrated diversity in their molecular 
features. In this study, the KPC-2 genes were encoded on 
a broad variety of plasmids, as shown by previous studies 
(22,35). These plasmids differed in size and incompatibil-
ity groups. Similar plasmids were observed among isolates 
with the same ST, whereas different plasmids were also as-
sociated with similar STs. Therefore, epidemiologic inves-
tigation of KPC producers should be performed at different 
molecular levels.
Tn4401 was present in all tested strains. The overall 
structure of Tn4401 seemed to be conserved, except for the 
100-bp to 200-bp deletion. Of the 16 isolates, 11 encoded 
the full-length Tn4401b isoform, 3 encoded the Tn4401a 
isoform containing a 100-bp deletion (ST 258), and 2 en-
coded the Tn4401c isoform containing a 200-bp deletion 
upstream of the blaKPC gene. These types of transposons 
tend to evolve by capturing various insertion sequences, 
as illustrated for the vanA-containing Tn1546 transposon 
(40). For Tn4401, three descriptions have been published in 
which different insertion sequences were present upstream 
of blaKPC-2 (22–24). None of these atypical structures were 
found in our strains. Observation of Tn4401 on different 
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Figure 2. A) Plasmid extractions of culture of clinical Klebsiella 
pneumoniae isolates that produce β-lactamase blaKPC-2 gene. B) 
Southern hybridization of transferred plasmid extraction, conducted 
with an internal probe for blaKPC-2. Lane 1, K. pneumoniae YC (11); 
lane 2, K. pneumoniae GR (21); lane 3, K. pneumoniae K271 
(25); lane 4, K. pneumoniae KN2303 (13); lane 5, K. pneumoniae 
KN633 (13); lane 6, K. pneumoniae INC H1521-6; lane 7, K. 
pneumoniae INC H1516-6; lane 8, K. pneumoniae HPTU 27635; 
lane 9, K. pneumoniae HPTU 2020532; lane 10, K. pneumoniae 
A28006 (16); lane 11, K. pneumoniae A28008 (16); lane 12, K. 
pneumoniae A28009 (16); lane 13, K. pneumoniae A28011 (16); 
lane 14, K. pneumoniae A33504 (16); lane 15, K. pneumoniae 
475; lane 16, K. pneumoniae 588; and lane 17, Escherichia coli 
50192 harboring 4 plasmids (7, 48, 66, and 154 kb). Diversity of K. pneumoniae That Produces KPC 
plasmids further supports the hypothesis that this transpo-
son contributes to the mobilization and dissemination of 
the blaKPC genes.
Our analysis of several K. pneumoniae isolates from 5 
geographic origins indicates the spread of different clones 
that were harboring different plasmids but with an identical 
genetic structure, Tn4401, that sustained a blaKPC gene ac-
quisition, which could likely be at the origin of the world-
wide spread of this emerging resistance gene. Finally, tak-
en together, our ﬁ  ndings and those of recent studies report a 
major KPC-producing clone with ST 258, even if novel ST 
types could also be evidenced, especially from Colombia. 
Our data suggest that KPC genes beneﬁ  t all molecular in-
gredients (transposon location, self-transferable plasmids, 
efﬁ  cient STs) by facilitating their rapid spread to K. pneu-
moniae and other bacterial species.
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